EG23908A - Stabilized antihistamine syrup - Google Patents

Stabilized antihistamine syrup

Info

Publication number
EG23908A
EG23908A EG60799A EG60799A EG23908A EG 23908 A EG23908 A EG 23908A EG 60799 A EG60799 A EG 60799A EG 60799 A EG60799 A EG 60799A EG 23908 A EG23908 A EG 23908A
Authority
EG
Egypt
Prior art keywords
stabilized
antihistamine syrup
antihistamine
syrup
stabilized antihistamine
Prior art date
Application number
EG60799A
Other languages
English (en)
Inventor
Farah J Munayyer
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22209512&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EG23908(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of EG23908A publication Critical patent/EG23908A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EG60799A 1998-06-01 1999-05-27 Stabilized antihistamine syrup EG23908A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/088,128 US6132758A (en) 1998-06-01 1998-06-01 Stabilized antihistamine syrup

Publications (1)

Publication Number Publication Date
EG23908A true EG23908A (en) 2007-12-30

Family

ID=22209512

Family Applications (1)

Application Number Title Priority Date Filing Date
EG60799A EG23908A (en) 1998-06-01 1999-05-27 Stabilized antihistamine syrup

Country Status (29)

Country Link
US (4) US6132758A (no)
EP (1) EP1082117B1 (no)
JP (2) JP4166948B2 (no)
AR (1) AR019147A1 (no)
AT (1) ATE257705T1 (no)
AU (1) AU754469B2 (no)
CA (1) CA2333528C (no)
CO (1) CO5011119A1 (no)
CR (1) CR6035A (no)
DE (1) DE69914192T2 (no)
DK (1) DK1082117T3 (no)
EG (1) EG23908A (no)
ES (1) ES2211192T3 (no)
GC (1) GC0000330A (no)
GT (2) GT199900072AA (no)
HN (1) HN1999000081A (no)
JO (1) JO2099B1 (no)
ME (1) ME01664B (no)
MY (1) MY123325A (no)
NL (1) NL1012191C2 (no)
NO (1) NO329124B1 (no)
NZ (1) NZ508037A (no)
PA (1) PA8474201A1 (no)
PE (1) PE20000565A1 (no)
PT (1) PT1082117E (no)
RS (1) RS49609B (no)
SV (1) SV1999000068A (no)
TW (1) TW589197B (no)
WO (1) WO1999062516A1 (no)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6132758A (en) * 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
US6211246B1 (en) * 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
AU2276801A (en) 1999-12-20 2001-07-03 Schering Corporation Extended release oral dosage composition
SK287684B6 (sk) * 1999-12-20 2011-06-06 Schering Corporation Pevná orálna farmaceutická dávková forma s predĺženým uvoľňovaním
JP2003518045A (ja) * 1999-12-21 2003-06-03 シェーリング コーポレイション 小児患者におけるアレルギー性状態および炎症性状態の処置のためのデスロラタジンの使用
US7405223B2 (en) 2000-02-03 2008-07-29 Schering Corporation Treating allergic and inflammatory conditions
JP5592042B2 (ja) * 2000-04-14 2014-09-17 ジェイ−メド ファーマシューティカルズ，インコーポレーティッド 鼻炎治療のための単一投与抗ヒスタミン薬／鬱血除去薬製剤
US20030216423A1 (en) * 2000-05-24 2003-11-20 Sergio Ulloa Stable liquid and solid formulations
BR0111018A (pt) * 2000-05-25 2004-02-17 Schering Corp Formulações estáveis lìquidas e sólidas
US20020035107A1 (en) * 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
IN192160B (no) * 2000-07-17 2004-02-28 Ranbaxy Lab
CA2417661A1 (en) * 2000-08-02 2002-02-07 Malope Company Limited Diagnosis and treatment of non-ulcer dyspepsia based on hypothalamic-pituitary-adrenal axis abnormality
US6720002B2 (en) 2001-07-20 2004-04-13 R.P. Scherer Technologies, Inc. Antihistamine formulations for soft capsule dosage forms
AR037131A1 (es) 2001-10-31 2004-10-20 Schering Corp Formulaciones de jarabe de ribavirina
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US20040101563A1 (en) * 2002-07-18 2004-05-27 Kundu Subhas C. Storage stable antihistaminic syrup formulations
US20100092562A1 (en) * 2002-11-26 2010-04-15 Hollenbeck R Gary Sustained-release drug delivery compositions and methods
US6635654B1 (en) 2003-01-09 2003-10-21 Allergan, Inc. Ophthalmic compositions containing loratadine
US8598219B2 (en) 2003-01-30 2013-12-03 Helsinn Healthcare Sa Liquid pharmaceutical formulations of palonosetron
JO2735B1 (en) 2003-01-30 2013-09-15 هيلسين هيلث كير أس ايه. Liquid pharmaceutical formations of balloonosterone
WO2004108700A1 (en) * 2003-03-12 2004-12-16 Teva Gyogyszergyar Reszvenytarsasag Processes for preparation of polymorphic forms of desloratadine
JP3881640B2 (ja) * 2003-08-08 2007-02-14 塩野義製薬株式会社 ロラタジンを含むドライシロップ剤
US20050069590A1 (en) 2003-09-30 2005-03-31 Buehler Gail K. Stable suspensions for medicinal dosages
WO2005076829A2 (en) * 2004-02-05 2005-08-25 Taro Pharmaceuticals U.S.A., Inc. Stable loratadine spill resistant formulation
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
GB0417909D0 (en) * 2004-08-11 2004-09-15 Novartis Consumer Health Sa Drop preparations
US20060093631A1 (en) * 2004-10-29 2006-05-04 Buehler Gail K Dye-free pharmaceutical suspensions and related methods
WO2006069213A1 (en) * 2004-12-22 2006-06-29 Schering Corporation Pharmaceutical formulations
US20070009558A1 (en) * 2004-12-22 2007-01-11 David Harris Sugar-free storage-stable antihistaminic syrups
US20060205752A1 (en) * 2005-03-14 2006-09-14 Keith Whitehead Stabilized hydrocodone pharmaceutical compositions with ethylenediaminetetraacetic acid
US20060275516A1 (en) * 2005-06-02 2006-12-07 Ram A N S Compositions and methods for the treatment of allergic rhinitis
ES2398960T3 (es) * 2005-06-17 2013-03-22 Aft Pharmaceuticals Limited Composición farmacéutica novedosa y su uso en un método para el tratamiento de pacientes con cangestión mucosa de las vías respiratorias altas
DOP2006000274A (es) 2005-12-14 2007-10-15 Sanofi Aventis Us Llc Formulación de suspensión de fexofenadina
WO2007143382A2 (en) * 2006-06-07 2007-12-13 Morton Grove Pharmaceuticals, Inc. Oral liquid loratadine formulations and methods
MX2009000121A (es) * 2006-06-29 2009-01-26 Schering Corp Jarabes antihistaminicos, estables en almacenamiento, sin azucar.
US20080014275A1 (en) * 2006-07-13 2008-01-17 Buehler Gail K Pharmaceutical suspensions and related methods
EP2120945A1 (en) * 2007-02-28 2009-11-25 Collegium Pharmaceutical, Inc. Antihistamine combination
PL2002733T3 (pl) * 2007-06-08 2017-06-30 The Procter And Gamble Company Kompozycja zawierająca miód naturalny i sposoby jej sporządzania
US20090082385A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched desloratidine
CA2690490C (en) 2010-01-19 2012-06-26 Accucaps Industries Limited Pharmaceutical formulations of loratadine for encapsulation and combinations thereof
JP5752578B2 (ja) * 2011-12-09 2015-07-22 ジェイ−メド ファーマシューティカルズ，インコーポレーティッド 鼻炎治療のための単一投与抗ヒスタミン薬／鬱血除去薬製剤
BR102012030828A2 (pt) 2012-12-03 2014-09-16 Ems Sa Composição farmacêutica compreendendo desloratadina e prednisolona e seu uso
CN104784110A (zh) * 2015-03-13 2015-07-22 浙江凯润制药有限公司 一种地氯雷他定糖浆制剂及其制备方法
WO2018058009A1 (en) 2016-09-26 2018-03-29 The Procter & Gamble Company Extended relief dosage form
CN109498569A (zh) * 2018-12-21 2019-03-22 湖北康源药业有限公司 一种氯雷他定糖浆及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985003707A1 (en) * 1984-02-15 1985-08-29 Schering Corporation 8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDYLIDENE)-5H-BENZO AD5,6 BDCYCLOHEPTA AD1,2-b BDPYRIDINE AND ITS SALTS, PROCESSES FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
US4783465A (en) * 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
GB8618847D0 (en) * 1986-08-01 1986-09-10 Smith Kline French Lab Pharmaceutical formulations
US4829064A (en) * 1987-06-08 1989-05-09 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4975426A (en) * 1987-06-08 1990-12-04 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
CA2146637C (en) * 1992-10-09 2001-02-13 James Grigg Upson Pharmaceutical compositions and methods for treating cold symptoms
EP0620001A1 (en) * 1993-04-16 1994-10-19 McNEIL-PPC, INC. Aqueous pharmaceutical suspension and process for preparation thereof
US5458879A (en) 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
JPH09124484A (ja) * 1995-10-27 1997-05-13 Schering Purau Kk 点眼剤
US5912007A (en) * 1996-02-29 1999-06-15 Warner-Lambert Company Delivery system for the localized administration of medicaments to the upper respiratory tract and methods for preparing and using same
HUP9904075A3 (en) * 1996-10-31 2002-02-28 Schering Corp Composition, for the treatment of asthma,containing loratadine and a decongestant
US5759579A (en) * 1996-12-05 1998-06-02 American Home Products Corporation Pharmaceutical suspension systems
US5939426A (en) * 1997-02-28 1999-08-17 Sepracor Inc. Methods for treating urinary incontinence using descarboethoxyloratadine
US6132758A (en) * 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup

Also Published As

Publication number Publication date
CA2333528A1 (en) 1999-12-09
JP2005015485A (ja) 2005-01-20
CA2333528C (en) 2002-07-02
JP2002516860A (ja) 2002-06-11
NL1012191C2 (nl) 2000-01-04
CR6035A (es) 2008-11-26
YU23599A (sh) 2001-07-10
NO20006079D0 (no) 2000-11-30
DK1082117T3 (da) 2004-05-03
DE69914192T2 (de) 2004-10-21
GC0000330A (en) 2007-03-31
ME01664B (me) 2007-06-04
AU4308599A (en) 1999-12-20
ES2211192T3 (es) 2004-07-01
PA8474201A1 (es) 2001-07-31
HN1999000081A (es) 1999-08-23
DE69914192D1 (de) 2004-02-19
NO329124B1 (no) 2010-08-30
US20030152595A1 (en) 2003-08-14
WO1999062516A1 (en) 1999-12-09
ATE257705T1 (de) 2004-01-15
SV1999000068A (es) 2000-06-23
JP4166948B2 (ja) 2008-10-15
PE20000565A1 (es) 2000-07-05
JO2099B1 (en) 2000-05-21
EP1082117B1 (en) 2004-01-14
US20020132805A1 (en) 2002-09-19
CO5011119A1 (es) 2001-02-28
US6514520B2 (en) 2003-02-04
EP1082117A1 (en) 2001-03-14
NO20006079L (no) 2000-11-30
TW589197B (en) 2004-06-01
MY123325A (en) 2006-05-31
NL1012191A1 (nl) 1999-12-03
GT199900072A (es) 2000-11-16
US6939550B2 (en) 2005-09-06
NZ508037A (en) 2002-11-26
US20050261280A1 (en) 2005-11-24
US6132758A (en) 2000-10-17
GT199900072AA (es) 2000-11-16
AU754469B2 (en) 2002-11-14
AR019147A1 (es) 2001-12-26
PT1082117E (pt) 2004-05-31
RS49609B (sr) 2007-06-04

Similar Documents

Publication Publication Date Title
GC0000330A (en) Stabilized antihistamine syrup
GB2347093B (en) Carbonation
HUP0104823A3 (en) Sugar wafers
GB9821096D0 (en) Dispensers
HU9900599D0 (en) Reduced fatcontaining chocolate
GB9818418D0 (en) Sub
EP1122011A4 (en) REVOLVER SUPPORT
AU137687S (en) Dispenser
GB2335415B (en) Dispensers
TW377873U (en) Structure improvement for handbell
GB9812397D0 (en) Mechanism
GB2341470B (en) Delayline
CA82933S (en) Beverage can
GB9828321D0 (en) Beer
TW375104U (en) Structure for corkscrew
PL324174A1 (en) Self-chilling beverage can
TW362579U (en) Structure for name-card case
GB9827885D0 (en) Drinks dispencer
TW353457U (en) Structure for Pao-Te bottle
TW356012U (en) Improved structure for bottle
AU135172S (en) Capping
AU135297S (en) Top
GB9815966D0 (en) Structure
TW392593U (en) Clipborad structure
TW379662U (en) Sun-shielding structure